Clinical Trial

Efficacy and Safety of Oral Rivaroxaban in Cerebrosinovenous Thrombosis

Name: Efficacy and Safety of Oral Rivaroxaban in Cerebrosinovenous Thrombosis — clinical trial record (NCT07523347)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Completed

View on ClinicalTrials.gov →

Summary

The study seeks to fill the gaps regarding safety and efficacy of rivaroxaban and standard anticoagulant. therefore the current study was planned with the aim to determine the safety and efficacy of rivaroxaban and standard anticoagulant in the treatment of cerebrosinovenous thrombosis (CSVT).

Trial Details

NCT Number	NCT07523347
Lead Sponsor	Muhammad Aamir Latif
Conditions	Cerebrosinovenous Thrombosis
Enrollment	75 participants
Start Date	2023-12-01
Primary Completion	2025-12-31 (estimated)
Study Completion	2025-12-31 (estimated)
Updated on ClinicalTrials.gov	2026-04-13